Dosage Hyper Pharma LLP - pharma in Kondotty, Kerala, India. Directors, charges & compliance details.
LLPIN AAN-3432 Incorporated 25 September 2018 ROC Ernakulam HQ Kondotty, Kerala, India
Active Limited Liability Partnership pharma
Contribution obligation
₹2.93 Cr
As per LLP agreement
LLP age
8 yrs
Est. 2018
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Ernakulam
ROC office
Incorporated
25 Sep 2018
Date of incorporation

About Dosage Hyper Pharma LLP

Data last updated:

Dosage Hyper Pharma LLP is a limited liability partnership (LLP) based in Kondotty, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Ernakulam, under LLPIN AAN-3432. Its GSTIN is 32AAPFD3123Q1Z8 (Kerala).

The LLP has a total obligation of contribution of β‚Ή2.93 Cr. It is led by designated partners Mohammed and Faizal Babu Ambalancheeri.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Room No.9/2290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India – 673638.

Company details

LLPIN AAN-3432
Incorporation Date 25 September 2018
Total Obligation of Contribution β‚Ή2.93 Cr
ROC Ernakulam
Company Status Active

Contact details

Dosage Hyper Pharma LLP's registered office is in Kondotty, Kerala.

  • Registered Address
    Room No.9/2290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India – 673638
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Dosage Hyper Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Dosage Hyper Pharma LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Dosage Hyper Pharma LLP, buy the company report.

Designated partners of Dosage Hyper Pharma LLP

Dosage Hyper Pharma has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
MohammedDesignated Partner25 Sep 20188 Years 1 MonthsCurrent
Faizal Babu AmbalancheeriDesignated Partner10 May 20233 Years 6 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dosage Hyper Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dosage Hyper Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAPFD3123Q1Z8KeralaActive02 Nov 2018

To see the full GST registrations and return filing status of Dosage Hyper Pharma LLP, buy the company report.

Recent activity

Dosage Hyper Pharma LLP has 7 designated partner changes on record since 2018: 6 appointments and 1 cessation. The latest: Faizal Babu Ambalancheeri was appointed as Designated Partner on 10 May 2023.

AGM
Dosage Hyper Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Dosage Hyper Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Appointed
Faizal Babu Ambalancheeri was appointed as Designated Partner.
Appointed
Mohammed Kutty Cholakkal was appointed as Partner.
Ceased
Moossakutty ceased to be Designated Partner.
Appointed
Abdussalam Pulikkal was appointed as Partner.
Appointed
Thuvakkat Sreenivasan was appointed as Partner.
Appointed
Mohammed was appointed as Designated Partner.
Appointed
Moossakutty was appointed as Designated Partner.
Incorporation
25 Sep 2018
Dosage Hyper Pharma Llp was registered on 25 Sep 2018 with Roc Ernakulam & aged 8 years 1 month as per MCA records.

Frequently asked questions

Dosage Hyper Pharma is an active limited liability partnership based in Kondotty, Kerala, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 September 2018 (8+ years old) and is registered under LLPIN AAN-3432.

Dosage Hyper Pharma has 2 current designated partners:

The latest financial statements of Dosage Hyper Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Dosage Hyper Pharma is 32AAPFD3123Q1Z8, registered in Kerala.

The LLPIN (Limited Liability Partnership Identification Number) of Dosage Hyper Pharma is AAN-3432. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Dosage Hyper Pharma was incorporated on 25 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.

Faizal Babu Ambalancheeri was appointed as Designated Partner on 10 May 2023. Mohammed Kutty Cholakkal was appointed as Partner on 10 May 2023. Moossakutty ceased to be Designated Partner on 10 May 2023. Dosage Hyper Pharma has 7 designated partner changes on record in total.

The registered office of Dosage Hyper Pharma is at Room No.92290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India – 673638.

Dosage Hyper Pharma operates in the pharma industry, in the drug formulation and development segment.

Dosage Hyper Pharma can be reached at its registered office: Room No.92290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India – 673638.